IMARC Group's report titled "Male External Catheters Market by Type (Disposable External Catheters, Reusable External Catheters), Application (Hospitals, Home Care, and Others), and Region 2024-2032", The global male external catheters market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.66% during 2024-2032. 

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/male-external-catheters-market/requestsample

Factors Affecting the Growth of the Male External Catheters Industry:

• Rising Prevalence of Urinary Incontinence:

The increasing prevalence of urinary incontinence among men, particularly due to age-related conditions, such as prostate issues and neurological disorders, is catalyzing the demand for male external catheters (MECs). The rising need for effective management solutions, as urinary incontinence affects daily activities and the quality of life of individuals, is propelling the growth of the market. MECs offer a non-invasive, comfortable, and secure method to manage incontinence, providing an essential solution for those affected. In line with this, the growing awareness among individuals about the diagnosis of urinary incontinence is positively influencing the market.                                                          

• Increasing Geriatric Population:

The escalating demand for MECs due to the rising geriatric population worldwide is contributing to the growth of the market. Older adults are more susceptible to conditions that compromise bladder control, necessitating reliable urinary management products. Moreover, increasing preferences for home healthcare solutions are propelling the market growth. These products enable older adults to manage their urinary incontinence independently, supporting their desire to live comfortably at home without much reliance on caregivers. The rising need for tailored healthcare products that address the unique challenges faced by elderly individuals is strengthening the market growth.

• Technological Advancements:

Innovations in MEC design and materials benefit in enhancing user comfort, device reliability, and ease of use. Technological improvements include the development of hypoallergenic adhesives that reduce skin irritation, more anatomically accurate designs for improved fit, and materials that minimize the risk of infection. These advancements address many of the traditional barriers to MEC use, making the devices more appealing to a broader range of users. Apart from this, key manufacturers are investing in research and development (R&D) activities to offer enhanced satisfaction among individuals with urinary incontinence, which is impelling the market growth.  

Leading Companies Operating in the Global Male External Catheters Industry:

• B. Braun SE, Becton Dickinson and Company
• BioDerm Inc.
• Coloplast Corp.
• Dileh Medical supplies co.
• Ltd., Hollister Incorporated
• Ribbel International Ltd.
• Sterimed Group
• Teleflex Incorporated
• Vitality Medical Inc.

Male External Catheters Market Report Segmentation:

By Type:

• Disposable External Catheters
• Reusable External Catheters
   

Disposable external catheters represent the largest segment as they offer enhanced convenience and hygiene.  

By Application:

• Hospitals
• Home Care
• Others
   

On the basis of the application, the market has been divided into hospitals, home care, and others.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the male external catheters market, which can be attributed to the well-established healthcare infrastructure and various healthcare policies.  

Global Male External Catheters Market Trends:

Rising preferences for non-invasive medical devices among individuals are propelling the growth of the market. MECs are non-invasive as compared to indwelling catheters and benefit in lowering the risk of urinary tract infections (UTIs) and other complications, making them a preferred choice for long-term urinary management.

In line with this, the growing awareness among the masses about urinary incontinence and its impact on quality of life, coupled with the increasing acceptance of the use of continence care products, is offering a positive market outlook. Furthermore, governing agencies of various countries are organizing campaigns to generate awareness about the use of MECs, which is supporting the market growth.  

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163